2016-2020年ICIs治疗疗效体系评估及方案优化

免疫检查点抑制剂在肺癌的治疗中取得显著疗效，已经成为晚期肺癌的标准免疫治疗方案。本数据集介绍以抗PD-1/PD-L1为代表的免疫检查点抑制剂治疗晚期肺癌的临床疗效评估办法，以及目前已经获得专家共识的免疫检查点抑制剂治疗晚期肺癌的不同治疗方案。

Immune checkpoint inhibitors (ICIs) have demonstrated remarkable therapeutic efficacy in lung cancer treatment and have been established as the standard immunotherapy regimen for advanced lung cancer. This dataset details the clinical efficacy evaluation approaches for advanced lung cancer therapy using immune checkpoint inhibitors, typically represented by anti-PD-1/PD-L1 agents, alongside the distinct treatment regimens for advanced lung cancer with immune checkpoint inhibitors that have reached expert consensus.